Pegfilgrastim biosimilar (mochida)

培非格司亭生物类似药（持田制药）

Report date: 2023/11/23 17:08:33

Base Information

Drug NamePegfilgrastim biosimilar (mochida)
Drug Alias NameMD110GBS-010
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsChemotherapy-Induced Febrile NeutropeniaFebrile Neutropenia
Global Approved IndicationsFebrile Neutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2023/09/25
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMochda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMochda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsFebrile Neutropenia
Inactive IndicationsChemotherapy-Induced Febrile Neutropenia

Other Information

ATC CodeN/A
Related LinksN/A